The Prevalence of Hepatitis B Virus Infection in the United States in the Era of Vaccination

Wasley, Annemarie; Kruszon-Moran, Deanna; Kuhnert, Wendi L.; Simard, Edgar P.; Finelli, Lyn; McQuillan, Geraldine M.; Bell, Beth P.

doi:10.1086/653622

Cited by 310 publications

(268 citation statements)

References 23 publications

Supporting

Mentioning

241

Contrasting

Unclassified

Order By: Relevance

“…According to data in the NHANES III (1988)(1989)(1990)(1991)(1992)(1993)(1994)) and a subsequent NHANES (1996-2006) survey, ageadjusted prevalence of chronic HBV infection defined as patients with positive anti-HBc and HBsAg in the non-Hispanic black population increased from 0.83% to 0.89%, the only group studied that showed an increase over the time surveyed [29]. For comparison, during the same period rates of chronic HBV in non-Hispanic whites fell from 0.21% to 0.09% [29].…”

Section: Increased Prevalence Of Hbv Infection In African Americansmentioning

confidence: 99%

Worse Outcomes among African Americans with Liver Cancer: What Might Cause the Disparity?

Ad¹

2017

Austin J Gastroenterol

View full text Add to dashboard Cite

Liver cancer remains an important cause of cancer mortality in the United States. Incidence of hepatocellular carcinoma (HCC), the most common histological cell type of liver cancer, has increased over the past 30 years. The statistics are particularly worrisome for African Americans. Their incidence of HCC far surpasses that of other races, particularly whites. Additionally, mortality for African Americans with HCC is also far worse. In a review of the literature, we found a stepwise progression of variables that may contribute to this observation. African Americans have the highest observed rates of infection with chronic hepatitis and are offered treatment less often for hepatitis C virus. The progression to cirrhosis is slower, which may complicate HCC surveillance. Regardless, they receive surveillance either biochemical or radiographic at a lower rate than patients of other races. Further, African Americans present at a more advanced stage and are referred for curative therapy less often. When African Americans do receive therapy, their outcomes are worse. Additional investigation is warranted as to whether differences in tumor biology may also play a role.

show abstract

Section: Increased Prevalence Of Hbv Infection In African Americansmentioning

confidence: 99%

Worse Outcomes among African Americans with Liver Cancer: What Might Cause the Disparity?

Ad¹

2017

Austin J Gastroenterol

View full text Add to dashboard Cite

show abstract

“…Da besonders die Impfung gegen Hepatitis B infolge erhöhten HBV-Risikos (3,3 % Prävalenz für HBsAg-Träger mit chronischer Hepatitis B bei CKD versus <2 % in der Normalbevölkerung Europas [36]) für Patienten mit CKD relevant ist, gilt ihr neben den anderen Impfungen des Erwachsenenalters spezifisches Augenmerk. Die Serokonversionsraten nach Hepatitis-B-Impfung bei CKD-Patienten liegen zwischen 30 und 80 %, abhängig vom Impfstoff und der Impfstrategie [37].…”

Section: Chronische Nierenerkrankungen/dialysepatientenunclassified

Impfungen bei Immundefekten/Immunsuppression – Expertenstatement und Empfehlungen

Wiedermann

Sitte

Burgmann

et al. 2016

Wien Klin Wochenschr

View full text Add to dashboard Cite

“…The prevalence of hepatitis B infection is disproportionately high among Asian and African American populations [12,13].…”

Section: Introductionmentioning

confidence: 99%

Hepatitis B Vaccination Rate in Patients with Diabetes: Assessment of Racial and Socioeconomic Disparity

Aytaman¹,

Ojike²,

Samantha³

et al. 2016

Int J Clin Endocrinol Metab

View full text Add to dashboard Cite

Introduction: Less hygienic use of blood glucose monitoring equipment such as blood glucose meters, lancets, fi nger stick devices or other diabetes-care equipment such as syringes or insulin pens by self-administration often exposes the diabetic patient to Hepatitis B infection. This study evaluates hepatitis B vaccination among individuals with diabetes. Methods:The study used data from the 2000-2013 National Health Interview Survey (NHIS). Vaccination rates among adult individuals with diabetes of various ethnic backgrounds was accessed and compared using chis-square tests. Multivariable logistic regression model was used to compare factors affecting hepatitis B vaccination among individuals with diabetes. Results:The crude rate of diabetes in this population was 5.4%. The rate of vaccination among individuals with diabetes differed across racial groups (Asians 31.8% vs. blacks 30.7%; and whites 26.5%; p<0.01). After multivariate regression, the leading factors affecting hepatitis B vaccination included Age (40-60 years) (OR=0.51, 95% CI=0.47-0.57, p<0.01), lack of college education (OR=0.71,95% CI=0.64-0.79, p<0.01), foreign birth (OR=0.83, 95% CI=0.72-0.95, p<0.01) , and Hispanic ethnicity (OR=0.88, 95% CI=0.78-1.00, P<0.05). Conclusion:Social and economic factors-education, insurance status, age, poverty level, and place of birth affect rates of vaccination among individuals with diabetes.

show abstract

The Prevalence of Hepatitis B Virus Infection in the United States in the Era of Vaccination

Abstract: HBV prevalence decreased among US children, which reflected the impact of global and domestic vaccination, but it changed little among adults, and approximately 730,000 US residents (95% confidence interval, 550,000-940,000) are chronically infected.

Cited by 310 publications

References 23 publications

Worse Outcomes among African Americans with Liver Cancer: What Might Cause the Disparity?

Worse Outcomes among African Americans with Liver Cancer: What Might Cause the Disparity?

Impfungen bei Immundefekten/Immunsuppression – Expertenstatement und Empfehlungen

Hepatitis B Vaccination Rate in Patients with Diabetes: Assessment of Racial and Socioeconomic Disparity

Contact Info

Product

Resources

About